GlassScriptPhysician profile
Daryl William Baron
NPI 1245293596
$448.36
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $83.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $171.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $59.25 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $54.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.69 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.31 | 2020 | |
| Astellas Pharma US INC | $21.00 | 2019 | |
| Amgen INC. | $19.18 | 2019 | |
| Boston Scientific Corporation | $17.06 | 2020 | |
| Horizon Therapeutics Plc | $17.03 | 2019 | |
| Glaxosmithkline, LLC. | $15.25 | 2019 | |
| Lilly USA, LLC | $12.55 | 2019 | |
| Merck Sharp & Dohme LLC | $12.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Baron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.